Dual Treatments Dual GLP- 1/GIP Receptor co-agonist Tirzepatide Tirzepatide is the first dual GLP- 1/GIP receptor co-agonist [98]
Phase Early escalation Weeks 5-8 Weekly Dose 4 mg Notes Increase by 2 mg every 4 weeks
Ashwagandha This adaptogenic herb has shown promise in improving sperm count, motility, and testosterone levels, while also reducing cortisol (stress hormone)
Gut dysbiosis may also directly affect the level of thyroid hormone through its characteristic deiodinase activity
Track Your Response: Keep detailed records of how you respond to BPC-157, noting any changes in recovery, symptoms, or side effects
The months of your life you spend on the protocol are the expensive part, and they deserve a vial you can trust